Treatment outcomes of macrolide-resistant mycobacterium avium complex lung disease Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016
Development of a prognostic scoring system for Mycobacterium avium complex lung disease Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016
Retrospective observation of mycobacterium avium complex lung disease followed without treatment Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management Year: 2013
LATE-BREAKING ABSTRACT: Intracellular ESAT-6: a new biomarker of mycobacterium tuberculosis infection? Source: Annual Congress 2013 –Diagnostic features of tuberculosis II Year: 2013
Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019
Efficacy and safety of kanamycin addition in patients with drug-refractory mycobacterium avium complex lung disease Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation Year: 2015
Treatment of refractory mycobacterium avium complex lung disease with a moxifloxacin-containing regimen Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013
LATE-BREAKING ABSTRACT: Poor outcome following lung transplantation in CF patients infected with mycobacterium abscessus appears to be associated with two genetic clusters of mycobacterium abscessus subspecies abscessus Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016
Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011
Isolation of M. abscessus from patients with M. avium complex (MAC) lung disease Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013
Clinical relevance of Mycobacterium simiae in pulmonary samples Source: Eur Respir J 2008; 31: 106-109 Year: 2008
Colonisation vs. infection of the lungs with non-tuberculous mycobacteria: defining the decision to treat Source: Annual Congress 2009 - Microbial colonisation or latency: a foot in the door to respiratory infections Year: 2009
Factors related to response to intermittent treatment of mycobacterium avium complex lung disease Source: Eur Respir J 2006; 28: Suppl. 50, 557s Year: 2006
Characteristics of patients with isolation of mycobacterium xenopi Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management Year: 2013
Infection or colonisation: indicators to initiate antimycobacterial treatment in nontuberculous mycobacterial infections Source: Annual Congress 2010 - Advances in the diagnosis of tuberculosis and nontuberculous mycobacterial infections: a joint ERS and ATS symposium Year: 2010
Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments Source: Eur Respir Rev, 31 (163) 210212; 10.1183/16000617.0212-2021 Year: 2022
A randomized, open-label, multicenter study of liposomal amikacin for inhalation in adult patients with nontuberculous mycobacteria (NTM) lung infections caused by mycobacterium avium complex (MAC) Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015
Paradoxical response during antibiotic treatment in patients with Mycobacterium avium complex lung disease Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis Year: 2020
Mycobacterium avium complex infection: phenotypes and outcomesSource: Eur Respir J, 50 (3) 1701380; 10.1183/13993003.01380-2017 Year: 2017
Clinical characteristics and outcomes of patients with Mycobacterium avium complex lung disease positive for Aspergillus precipitating antibody Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019